
Heart Health Report
: Analysis on the Market, Trends, and TechnologiesThe heart health sector is experiencing significant expansion, evidenced by over 11 249 articles and 4 270 companies active in the field. Despite this vibrant ecosystem, cardiovascular disease remains the leading cause of death in the United States, accounting for 21 percent of all fatalities in 2022 (Cardiovascular disease in the U.S. – Statistics & Facts). This juxtaposition of growing innovation and persistent mortality underscores the critical need for early detection, preventive strategies, and patient-centric technologies to shift clinical outcomes.
We updated this report 8 days ago. Missing information? Contact us to add your insights.
Topic Dominance Index of Heart Health
The Topic Dominance Index combines the distribution of news articles that mention Heart Health, the timeline of newly founded companies working within this sector, and the share of voice within the global search data
Key Activities and Applications
- Cardiovascular Disease Prevention and Heart Failure Management: Emphasis on primordial prevention through lifestyle modification from childhood and the advancement of left ventricular assist devices for patients with advanced heart failure (5 trends in cardiology to watch).
- Risk Factor Management: Systematic identification and control of hypertension, high cholesterol, diabetes, and obesity via clinician-led interventions and digital therapeutics.
- Health Monitoring and Tracking: Deployment of wearable sensors and telehealth platforms for continuous surveillance of blood pressure and lipid levels, enabling proactive adjustments to therapy (Remote health care delivery program improves blood pressure and cholesterol levels).
- Personalized Medicine and Biomarker Testing: Adoption of precision assays, including emerging blood-based tests that predict heart attack risk and guide individualized treatment plans (Blood test promises safer heart attack prevention).
Emergent Trends and Core Insights
- Rising Heart Failure Rates: Heart failure prevalence and hospitalizations are climbing, particularly among adults aged 35–64, signaling escalating demand for advanced support devices and pharmacotherapies (Cardiology Experts Warn of Rising Heart Failure Rates and Worsening Disparities).
- Persistent Racial Disparities: In 2022, Black adults experienced a cardiovascular mortality rate of 597 per 100 000 versus 271 per 100 000 among Asian or Pacific Islander adults, highlighting an urgent equity challenge (Cardiovascular disease mortality rates among U.S. adults 2010-2022, by race).
- Heightened Focus on Women’s Heart Health: New data reveal that lifestyle risk factors impose a disproportionate cardiovascular risk on women, prompting tailored screening and education programs (Lifestyle risks weigh heavier on women’s hearts).
- Environmental Determinants: Recent studies link air pollution exposure to increased arrhythmia incidence, underscoring the role of environmental monitoring in cardiac risk models (Polluted air, disturbed hearts: Study ties air quality to cardiac health).
- Digital Transformation of Care: Integration of AI-powered diagnostics, telecardiology platforms, and cloud-based health records is reconfiguring patient pathways toward remote assessment and management (Cardiovascular Health).
Technologies and Methodologies
- Advanced Imaging and Scoring Systems: Coronary artery calcium scoring through CT provides quantitative plaque assessment for precise risk stratification (Coronary Artery Calcium Score Predicts Heart Disease Risk).
- Non-Invasive Biomarker Assays: Emergent blood tests measure panels of proteins and metabolites to forecast cardiac events, enabling intervention before clinical presentation.
- Integrated Digital Platforms: Cloud-based telemedicine solutions and virtual cardiology suites facilitate remote consultations, continuous monitoring, and seamless data sharing between patients and providers.
- Standardized Health Metrics: Adoption of the American Heart Association’s Life’s Essential 8 framework offers a quantifiable measure of cardiovascular health across diet, activity, sleep, and other factors (Only 1 in 5 People in the U.S. Has Optimal Heart Health).
- Wearable Sensor Technology: Miniaturized patches and smart devices capture ECG, heart rate variability, and hemodynamic signals continuously, feeding AI engines for real-time risk alerts.
Heart Health Funding
A total of 580 Heart Health companies have received funding.
Overall, Heart Health companies have raised $22.2B.
Companies within the Heart Health domain have secured capital from 2.0K funding rounds.
The chart shows the funding trendline of Heart Health companies over the last 5 years
Heart Health Companies
-
CardioRisk Laboratories
Specializes in Carotid Intima-Media Thickness screening to detect arterial plaque early, achieving 98.6 percent sensitivity in a 100 000 person-year study. Their non-invasive exam requires no radiation or blood draws, supporting both clinical care and large-scale epidemiologic research. -
Cardio-Phoenix
Developer of Cardio-HART, the first integrated system combining AI-driven 12-lead ECG, phonocardiography, and echocardiography. It identifies 14 cardiac abnormalities—including HFpEF and HFrEF—at the point of primary care, streamlining referral to specialists. -
DeepCardio LLC
Pioneers in AI-based analysis of normal sinus rhythm ECGs to predict arrhythmia risk before clinical symptoms emerge. Their technology is deployed globally for at-home and point-of-care screening, turning a 10-second ECG into a comprehensive cardiac health status report. -
D-Heart
Provides a CE-marked, smartphone-based ECG device capable of recording 8- and 12-lead traces independently. Its AI-driven image-processing allows users and clinicians to perform hospital-grade ECGs anywhere, supporting telecardiology and longitudinal tracking.
Gain a competitive edge with access to 4.6K Heart Health companies.

4.6K Heart Health Companies
Discover Heart Health Companies, their Funding, Manpower, Revenues, Stages, and much more
Heart Health Investors
Leverage TrendFeedr’s sophisticated investment intelligence into 1.9K Heart Health investors. It covers funding rounds, investor activity, and key financial metrics in Heart Health. investors tool is ideal for business strategists and investment experts as it offers crucial insights needed to seize investment opportunities.

1.9K Heart Health Investors
Discover Heart Health Investors, Funding Rounds, Invested Amounts, and Funding Growth
Heart Health News
TrendFeedr’s News feature provides a historical overview and current momentum of Heart Health by analyzing 11.7K news articles. This tool allows market analysts and strategists to align with latest market developments.

11.7K Heart Health News Articles
Discover Latest Heart Health Articles, News Magnitude, Publication Propagation, Yearly Growth, and Strongest Publications
Executive Summary
The heart health landscape is rapidly evolving toward preventive, data-driven paradigms. Innovation centers on early detection technologies—from advanced imaging and biomarker assays to AI-empowered ECG analysis and continuous wearable monitoring. Coupled with personalized risk assessment models and integrated digital platforms, these developments offer a path to reduce mortality, address disparities, and optimize patient engagement. Stakeholders who align clinical workflows with these emerging tools and methodologies will be best positioned to improve cardiovascular outcomes and drive the next wave of industry growth.
Interested in contributing your expertise on trends and tech? We’d love to hear from you.